Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat mild, moderate and severe tinnitus. With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus.
Neuromonics Tinnitus Treatment (NTT)
The NTT works with the Neuromonics Oasis, a non-invasive, compact, lightweight device that uses music – programmed for each patient’s individual audiological profile – to deliver a neural stimulus that targets the brain’s auditory pathways. The NTT targets the neurological processes of tinnitus: its audiological, attention-based and emotional aspects.
Oasis : Works with the clinically administered and monitored Neuromonics Tinnitus Treatment over a pof six-eight months, individually programmed music to target auditory pathways. For moderate to severe tinnitus disturbance.
Haven : Prescribed, personally tuned device to provide on-demand tinnitus relief.
Sanctuary : Device with pre-set hearing profiles and functions with simple setup and fitting, offering immediate, situational relief. For mild to moderate tinnitus disturbance.
- Non-invasive, compact, lightweight devices
- Function like familiar consumer music players
- Easy to use in daily activity
- Reduction in tinnitus disturbance for more than 90 percent of patients in clinical trial setting
More than 400 licensed audiologists across four continents administer the Neuromonics Tinnitus Treatment. All are trained by Neuromonics.
- New Zealand
- United States
- P O BOX 351886
- Westminster, CO 80035-1886
- Duane Knight
- Neuromonics, Inc.
- Aimee Bennett
- Fagan Business Communications, Inc.